Nov 07, 2024 / 01:30PM GMT
Operator
Greetings and welcome to Arena Pharmaceuticals third quarter, 2024 earnings call.
At this time, all participants are in listen-only mode.
A question and answer session will follow the formal presentation.
If anyone should require assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Andrea Christopher, head of Corporate Communications and Investor Relations for Arena Pharmaceuticals. Thank you. You may now begin.
Andrea Christopher Aurinia Pharmaceuticals Inc.-Head of Corporate Communications&Investor Relations
Thank you operator and thank you to everyone for joining today's call and webcast. Joining me on the call this morning are Peter Greenleaf Aena's President and Chief Executive Officer, Joe Miller, our Chief Financial Officer and Dr Greg Keenan, our Chief Medical Officer. Today we will review and discuss Orin's 2024 3rd quarter financial and operational
Q3 2024 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Nov 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers